TrialThe Journal of infectious diseases2022

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.

Eduardo López-Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.